BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ghoneim S, Dhorepatil A, Shah AR, Ram G, Ahmad S, Kim C, Asaad I. Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. World J Hepatol 2020; 12(7): 378-388 [PMID: 32821336 DOI: 10.4254/wjh.v12.i7.378]
URL: https://www.wjgnet.com/1948-5182/full/v12/i7/378.htm
Number Citing Articles
1
D. V. Garbuzenko, D. V. Belov. Non-alcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular diseasesExperimental and Clinical Gastroenterology 2021; (10): 22 doi: 10.31146/1682-8658-ecg-194-10-22-34
2
Shun-Yi Shi, Fang Jia, Meng-Fei Wang, Ya-Feng Zhou, Jian-Jun Li. Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and ControversiesCurrent Atherosclerosis Reports 2023; 25(10): 751 doi: 10.1007/s11883-023-01146-7
3
Manya Prasad, Sunanda Gupta, Shiv K. Sarin. The Independent Association of Non-alcoholic Fatty Liver Disease With Incident Cardiovascular Disease: A GRADE Evaluation of the Evidence Through a Systematic Review and Meta-analysisJournal of Clinical and Experimental Hepatology 2024; 14(1): 101277 doi: 10.1016/j.jceh.2023.08.013
4
Andreas Daiber, Omar Hahad, Ioanna Andreadou, Sebastian Steven, Steffen Daub, Thomas Münzel. Redox-related biomarkers in human cardiovascular disease - classical footprints and beyondRedox Biology 2021; 42: 101875 doi: 10.1016/j.redox.2021.101875
5
Daqing Zhang, Zhen Mi, Jiya Peng, Tiangui Yang, Yuze Han, Yujia Zhai, Chenliang Song, Xianzhuo Teng, Wei Sun, Jing Guo, Kabeya Paulin Bilonda. Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular DiseasesJournal of Cardiovascular Pharmacology 2023; 81(5): 327 doi: 10.1097/FJC.0000000000001418
6
Lea Strohm, Andreas Daiber, Henning Ubbens, Roopesh Krishnankutty, Matthias Oelze, Marin Kuntic, Omar Hahad, Veronique Klein, Imo E. Hoefer, Alex von Kriegsheim, Hartmut Kleinert, Dorothee Atzler, Philipp Lurz, Christian Weber, Philipp S. Wild, Thomas Münzel, Christoph Knosalla, Esther Lutgens, Steffen Daub. Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studiesBasic Research in Cardiology 2024;  doi: 10.1007/s00395-024-01045-1
7
Jorge E. Jalil, Luigi Gabrielli, María Paz Ocaranza, Paul MacNab, Rodrigo Fernández, Bruno Grassi, Paulina Jofré, Hugo Verdejo, Monica Acevedo, Samuel Cordova, Luis Sanhueza, Douglas Greig. New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A ReviewInternational Journal of Molecular Sciences 2024; 25(8): 4407 doi: 10.3390/ijms25084407
8
Qiong Lv, Huashan Zhao. The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysisAnnals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2306192
9
Marin Kuntic, Ivana Kuntic, Omar Hahad, Jos Lelieveld, Thomas Münzel, Andreas Daiber. Impact of air pollution on cardiovascular agingMechanisms of Ageing and Development 2023; 214: 111857 doi: 10.1016/j.mad.2023.111857
10
Ioanna Andreadou, Andreas Daiber, Gary F. Baxter, Maria Felice Brizzi, Fabio Di Lisa, Nina Kaludercic, Antigone Lazou, Zoltán V. Varga, Coert J. Zuurbier, Rainer Schulz, Péter Ferdinandy. Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signalingFree Radical Biology and Medicine 2021; 166: 33 doi: 10.1016/j.freeradbiomed.2021.02.012
11
Aneesh Dhore-patil, Tariq Thannoun, Rohan Samson, Thierry H. Le Jemtel. Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of ObesityFrontiers in Physiology 2022; 12 doi: 10.3389/fphys.2021.785879